Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Horst Zincke

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
The Journal of Urology|July 20, 2002
Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient ageSusan D Sweat, Erik J Bergstralh, Jeffrey Slezak, et al.
The Journal of Urology|October 9, 2003
The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomyJohn F Ward, Michael L Blute, Jeffrey Slezak, et al.
BJU International|June 26, 2004
The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombusMichael L Blute, Bradley C Leibovich, Christine M Lohse, et al.
Urology|April 3, 2002
Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomyWeber K Lau, John C Cheville, Michael L Blute, et al.
The Journal of Urology|December 18, 2001
Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: influence of concomitant pathological variablesWeber K Lau, Erik J Bergstralh, Michael L Blute, et al.
The American Journal of Surgical Pathology|April 30, 2003
Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinomaJohn C Cheville, Christine M Lohse, Horst Zincke, et al.
The Journal of Urology|July 13, 2004
A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinomaMichael L Blute, Bradley C Leibovich, John C Cheville, et al.
BJU International|March 30, 2005
Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcomeJohn F Ward, Jeffrey M Slezak, Michael L Blute, et al.
American Journal of Clinical Pathology|December 11, 2002
Comparison of standardized and nonstandardized nuclear grade of renal cell carcinoma to predict outcome among 2,042 patientsChristine M Lohse, Michael L Blute, Horst Zincke, et al.
Urology|September 8, 2004
Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomyDavid S Dimarco, Christine M Lohse, Horst Zincke, et al.
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
The Journal of Urology|July 20, 2002
Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient ageSusan D Sweat, Erik J Bergstralh, Jeffrey Slezak, et al.
The Journal of Urology|October 9, 2003
The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomyJohn F Ward, Michael L Blute, Jeffrey Slezak, et al.
BJU International|June 26, 2004
The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombusMichael L Blute, Bradley C Leibovich, Christine M Lohse, et al.
Urology|April 3, 2002
Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomyWeber K Lau, John C Cheville, Michael L Blute, et al.
The Journal of Urology|December 18, 2001
Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: influence of concomitant pathological variablesWeber K Lau, Erik J Bergstralh, Michael L Blute, et al.
The American Journal of Surgical Pathology|April 30, 2003
Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinomaJohn C Cheville, Christine M Lohse, Horst Zincke, et al.
The Journal of Urology|July 13, 2004
A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinomaMichael L Blute, Bradley C Leibovich, John C Cheville, et al.
BJU International|March 30, 2005
Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcomeJohn F Ward, Jeffrey M Slezak, Michael L Blute, et al.
American Journal of Clinical Pathology|December 11, 2002
Comparison of standardized and nonstandardized nuclear grade of renal cell carcinoma to predict outcome among 2,042 patientsChristine M Lohse, Michael L Blute, Horst Zincke, et al.
Urology|September 8, 2004
Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomyDavid S Dimarco, Christine M Lohse, Horst Zincke, et al.
Pageof 10